Trials / Withdrawn
WithdrawnNCT04542395
COVID-2019 Testing and Vaccination Among African American and Latinx Public Housing Residents
Multilevel Participatory Intervention to Reduce Barriers and Promote Social and Behavioral Facilitators of COVID-19 Testing Among African Americans and Latinx Public Housing Residents
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Charles Drew University of Medicine and Science · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This proposal seeks to enhance acceptability and uptake of COVID-19 testing and vaccination to engage African American and Latinx public housing residents in South Los Angeles. Given the multiple disparities experienced by public housing residents, the investigators will utilize a theoretically-based, multidisciplinary and culturally tailored intervention to reduce barriers and implement innovate strategies to engage this population in the uptake of COVID-19 testing and vaccination.
Detailed description
Through the engagement and empowerment of 15 trained COVID-19 health ambassadors, the investigators will jointly implement and evaluate a theoretically based and culturally-sensitive socio-behavioral intervention that will: a) reduce mistrust, fatalistic beliefs, and related psychosocial barriers that hinder COVID-19 testing and vaccination; b) increase receptivity and willingness for uptake of COVID-19 testing and vaccination; and c) assess perceived impact of psychosocial and health outcomes related to COVID-19 testing and vaccination for 310 African American and Latinx public housing residents.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Increasing Willingness and Uptake of COVID-19 Testing and Vaccination | Provide/enhance knowledge, modify attitudes, motivate and provide skills and resources to reduce COVID-19 related risk and challenges and increase willingness and uptake in COVID-19 testing and vaccination. |
Timeline
- Start date
- 2023-06-01
- Primary completion
- 2025-11-30
- Completion
- 2025-11-30
- First posted
- 2020-09-09
- Last updated
- 2022-08-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04542395. Inclusion in this directory is not an endorsement.